The not-for-profit (NFP) [b]International Partnership for Microbicides[/b] has received worldwide rights to a promising HIV prevention medicine, called dapivirine, from [b]Janssen R&D Ireland[/b], reports [s]News-Medical[/s]. The agreement expands on IPM’sexisting rights to develop, manufacture and commerc ialise dapivirine-based products for use by women in developing countries and will now give these women access to products containing dapivirine, such as a v aginal ring that combines dapivirine and a contraceptive.
[link url=http://www.news-medical.net/news/20140508/IPM-gains-exclusive-worldwide-rights-to-promising-HIV-prevention-medicine-from-Janssen-RD-Ireland.aspx]Full News-Medical report[/link]